Stock Details
JNJ is Johnson & Johnson's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 170.30$. Average daily volumn in 3 months 7.03M. Market cap 460.46B



Stock symbol : JNJ. Exchange : NYSE. Currency : USD
Lastest price : 176.12$. Total volume : 5.50M. Market state POST
Click reload if you want to check the lastest price on market!!!

Johnson & Johnson (JNJ)
Last Price
176.12$
Change
-2.66
Volume
5.50M

Previous Close178.78
Open179.92
Day Range175.93-180.00
Bid176.32 x 900
Ask176.35 x 800
Volume5.5M
Average Volume7.03M
Market Cap460.46B
Beta0.57
52 Week Range155.72-186.69
Trailing P/E24.53
Foward P/E16.93
Dividend (Yield %)2.53%
Ex-Dividend Date2022-11-21



Financial Details


According to Johnson & Johnson's financial reports the company's revenue in 2022 were 93.78B an increase( +13.41%) over the years 2021 revenue that were of 82.58B. In 2022 the company's total earnings were 20.88B while total earnings in 2021 were 14.71B( +42.86%).


Loading ...



Organization

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC... allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.

Market Cap:
460.46B
Revenue:
93.78B
Total Assets:
182.02B
Total Cash:
14.49B



News about "Johnson & Johnson"

johnson-johnson-reducing-corporate-risk-and-increasing-growth-image

Johnson & Johnson: Reducing Corporate Risk And Increasing Growth

Source from : Seeking Alpha - 10 hours ago

Johnson & Johnson is a growing company in the pharmaceutical and medical device industries. The company will split off the consumer health segment to focus on the pharmaceutical and MedTech industry.See details»


Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know

Source from : Yahoo Finance - 5 days ago

Johnson & Johnson (JNJ) closed at $178 in the latest trading session, marking a +1.08% move from the prior day. This move lagged the S&P 500's daily gain of 3.1%. Elsewhere, the Dow gained 2.18% ...See details»


Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board

Source from : Yahoo - 6 days ago

Alex Gorsky to Step Down After 30-Year Career at Johnson & Johnson NEW BRUNSWICK, N.J., November 30, 2022--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) today announced that its Board of ...See details»


Johnson & Johnson CEO Joaquin Duato to take additional role of chairman

Source from : CNBC - 5 days ago

Johnson & Johnson said on Wednesday its board has elected Chief Executive Officer Joaquin Duato to take on the additional role of chairman, effective in January. Duato will succeed Alex Gorsky ...See details»


Johnson & Johnson CEO to be board chair

Source from : Becker's Spine Review - 5 days ago

Johnson & Johnson's CEO, Joaquin Duato, was elected to chair of the board, the medtech company said Nov. 30. Mr. Duato will add the chair title in January 2023, and he will replace Alex Gorsky, ...See details»


This Pharmaceutical Company Is A Better Pick Over Johnson & Johnson Stock

Source from : Forbes - 13 days ago

We think AbbVie stock (NYSE: ABBV) is currently a better pick than its industry peer, Johnson & Johnson stock (NYSE: JNJ), given its better growth prospects. Both companies are comparable in terms ...See details»


dwayne-johnson-posts-family-video-of-one-of-the-greatest-and-most-moving-moments-of-his-life-image

Dwayne Johnson posts family video of one of 'the greatest and most moving moments' of his life

Source from : ABC - 11 hours ago

Dwayne Johnson recently shared video of the sweet moment with his family he called "one of the greatest and most moving moments" of his life. The actor, his wife Lauren Hashian and their daughters, ...See details»


Horizon Therapeutics Surges on Takeover Talk, With Johnson & Johnson Among Its Suitors

Source from : Barron's - 6 days ago

Horizon (ticker: HZNP) said it was in early talks with Amgen (AMGN), Johnson & Johnson (JNJ) subsidiary Janssen Global Services, and Sanofi (SNY), confirming an earlier report of takeover interest ...See details»


Johnson & Johnson Vision aims to invest more in Jacksonville

Source from : The Business Journals - 5 days ago

Johnson & Johnson Vision has been in Jacksonville for over four decades, and the company is planning more growth and investment in the area, according to its leader. โ€œWe'll continue to invest ...See details»


49ers-sign-veteran-quarterback-josh-johnson-for-fourth-time-image

49ers Sign Veteran Quarterback Josh Johnson for Fourth Time

Source from : Sports Illustrated on MSN - 8 hours ago

The journeyman QB will add experience to a banged-up quarterback room.With Jimmy Garoppolo out for the season, theย 49ersย are adding depth to the quarterback room. San Francisco announced it has signed ...See details»


49ers-announce-theyve-signed-josh-johnson-to-one-year-deal-image

49ers announce theyโ€™ve signed Josh Johnson to one-year deal

Source from : NBC Sports - 9 hours ago

After Jimmy Garoppolo suffered a season-ending foot injury on Sunday, reports emerged that San Francisco would sign quarterback Josh Johnson off the Broncosโ€™ practice squad to back up Brock Purdy.Now ...See details»


professor-christine-kreuder-johnson-to-serve-as-us-science-envoy-image

Professor Christine Kreuder Johnson to Serve as U.S. Science Envoy

Source from : ucdavis.edu - 9 hours ago

UC Davis Professor Christine Kreuder Johnson is a newly elected U.S. Science Envoy, the U.S. Department of State announced.See details»


49ers' Josh Johnson: Back with 49ers

Source from : CBSSports.com - 14 hours ago

This marks Johnson's fourth stint with the 49ers in some capacity, but he now is only one snap away from getting his first game action with the team. On Sunday, Jimmy Garoppolo likely was lost for the ...See details»


jaylon-johnson-named-bears-2022-walter-payton-man-of-the-year-nominee-image

Jaylon Johnson named Bears' 2022 Walter Payton Man of the Year nominee

Source from : YAHOO!News on MSN - 12 hours ago

Bears cornerback Jaylon Johnson has been selected as Chicagoโ€™s 2022 nominee for the Walter Payton Man of the Year Award, which recognizes the best of the NFLโ€™s commitment to philanthropy and community ...See details»